Ceeto Capital Group’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-2,000
Closed -$197K 137
2019
Q3
$197K Sell
2,000
-1,000
-33% -$95K 0.14% 122
2019
Q2
$277K Sell
3,000
-12,400
-81% -$1.18M 0.2% 104
2019
Q1
$1.45M Hold
15,400
1.07% 27
2018
Q4
$987K Buy
15,400
+500
+3% +$36.9K 0.81% 45
2018
Q3
$1.33M Hold
14,900
0.92% 33
2018
Q2
$1.18M Hold
14,900
0.89% 34
2018
Q1
$1.33M Buy
14,900
+400
+3% +$38.4K 1.01% 30
2017
Q4
$1.51M Buy
14,500
+1,500
+12% +$169K 1.08% 25
2017
Q3
$1.9M Buy
+13,000
New +$1.77M 1.42% 12

Other funds holding CELG

Ceeto Capital Group's CELG Position: Q4 2019 in Review

Ceeto Capital Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,000 shares — an estimated $197K sold.

Ceeto Capital Group first reported a position in CELG in Q3 2017 and held it in 9 quarters. The position peaked at $1.9M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Ceeto Capital Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Ceeto Capital Group sold 2,000 Celgene Corp shares in Q4 2019, an estimated $197K.
  • Ceeto Capital Group first reported a position in Celgene Corp in Q3 2017 and held it in 9 quarters.
  • Ceeto Capital Group's Celgene Corp position peaked at $1.9M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Ceeto Capital Group's 13F filing for Q4 2019, filed 13 Feb 2020.